Functional IL18 polymorphism and susceptibility to Chronic Chagas Disease

Luciana Gabriel Nogueira1, Amanda Farage Frade1, Barbara Maria Ianni2

  • 1Laboratory of Immunology, Heart Institute (InCor), School of Medicine, University of São Paulo, São Paulo, Brazil; Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil; Institute for Investigation in Immunology (iii), INCT, São Paulo, Brazil.

Cytokine
|March 7, 2015
PubMed

Insights

A specific gene variant (rs2043055) in Interleukin-18 (IL-18) may influence the severity of Chronic Chagas Disease cardiomyopathy. This finding could help predict disease progression in patients with Chagas disease.

Area of Science:

  • Immunogenetics
  • Cardiovascular Medicine
  • Infectious Diseases

Background:

  • Chronic Chagas Disease cardiomyopathy (CCC) is a severe inflammatory heart condition affecting 30% of Trypanosoma cruzi infected individuals.
  • Myocarditis, driven by Th1 T cells, is central to CCC pathogenesis, with local Interleukin-18 (IL-18) expression potentially creating a positive feedback loop with IFN-γ.
  • The role of IL-18 in CCC susceptibility requires further investigation.

Purpose of the Study:

  • To investigate the association between a single nucleotide polymorphism (SNP) in the IL-18 gene and the risk of developing Chagas cardiomyopathy.
  • To assess the contribution of IL-18 genetic variations to the susceptibility and outcome of Chronic Chagas Disease.

Main Methods:

  • Genotyping analysis of the rs2043055 marker within the IL18 gene.
  • Comparison of genotype frequencies between Chagas disease cardiomyopathy patients (n=849) and asymptomatic individuals (n=202).

Main Results:

  • Significant differences in genotype frequencies were observed between moderate and severe CCC patients exhibiting ventricular dysfunction.
  • The IL18 rs2043055 polymorphism was associated with variations in CCC severity.

Conclusions:

  • The IL18 rs2043055 polymorphism, or a closely linked SNP, may play a role in modulating the clinical outcome of Chagas cardiomyopathy.
  • This genetic marker could potentially serve as a predictor for CCC progression.
Abstract